Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) to predict succeeding onset of immune-related adverse events (irAEs).
Rika Kizawa,Yuji Miura,Yasuhiro Oda, Yukiko Nagaoka,Yukinori Ozaki,Chihiro Kondoh,Shuhei Moriguchi,Yui Takahashi,Kazumasa Ogawa, Yuko Tanabe-Hashimoto,Shuichi Taniguchi,Toshikazu Okaneya,Akiko Kishi,Nobukazu Hayashi,Kazuma Kishi,Toshimi Takano,Jun Masuda ANNALS OF ONCOLOGY（2019）
AI 理解论文
溯源树
样例
